syngem
Vaccineexperimental
Clinical trial activity
4 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2009 (NCT00848211)
Timeline
2000s
- Jan 1, 2009
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- RSV F-proteinImmunity, active
RSV F-protein immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- syngem
- tuti-16
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02958540 | Phase 1 | Oct 1, 2016 | Mucosis BV, University of London |
| NCT01335191 | Phase 1/Phase 2 (Phase 2) | Jun 1, 2011 | Clinilabs, Thymon, LLC |
| NCT01144026 | Phase 1/Phase 2 (Phase 2) | Sep 1, 2010 | Clinilabs, Thymon, LLC |
| NCT00848211 | Phase 1/Phase 2 (Phase 2) | Feb 1, 2009 | Conant Medical Clinical Research, Thymon, LLC |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Thymon, LLC | For profit | 3 | 3 | 1 | 2009 |
| Clinilabs | For profit | 2 | 0 | 1 | 2010 |
| Conant Medical Clinical Research | Academic/Hospital | 1 | 0 | 1 | 2009 |
| Mucosis BV | For profit | 1 | 1 | 1 | 2016 |
| University of London | Academic/Hospital | 1 | 0 | 1 | 2016 |
5 organizations
Page 1 / 1